Home Healthcare Pharmaceuticals Food Allergy Market

Food Allergy Market Size, Share & Trends Analysis Report By Treatment (Antihistamines, Adrenaline, Oral Immunotherapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Food Allergy Market Size

The global food allergy market size was valued at USD 40.14 billion in 2025 and is projected to grow from USD 42.27 billion in 2026 to USD 63.89 billion by 2034, registering a CAGR of 5.3% during the forecast period from 2026 to 2034. North America dominated the food allergy market with a market share of 38.4% in 2025.

The market for food allergy is growing strongly and represents a major area of growth. It offers a full range of allergy management and treatment options. Advanced testing methods, such as skin pricks and blood tests are used for the identification of food triggers in the diagnostics segment. Lifesaving epinephrine autoinjectors for severe reactions are provided in the emergency response section. The preventive segment is most promising, offering a growing choice of allergen-free food products and contributing to inclusiveness and improving the quality of life for those suffering from allergy. This market is set to grow further as individuals are empowered to control their allergies and make a success of them.

The market for food allergy is expected to grow strongly, driven by a significant increase in the number of diagnosed cases among children. The demand for improved diagnostic tools, effective treatments such as erythropoietic autoinjectors and development of allergen free food products is a result of this growth in allergy cases that creates an extensive market for companies to meet these needs.

Food Allergy Market Size

Download a Free Sample To learn more about this report.

Treatment Insights

The market is segmented into antihistamines, adrenaline, oral immunotherapy, and others. Oral Immunotherapy dominates the treatment segment. The future of food allergy treatment will be dominated by oral immunotherapy (OIT). Unlike medication, it desensitizes the immune system to offer a potential cure rather than relief of symptoms. The growth of the OIT market is driven by this shift from management to treatment.

Food Allergy Market Size By Segments

Request Customizationto receive a tailored report.

Distribution Channel Insights

The market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Hospital pharmacy dominates the distribution channel segment. Due to two key factors, hospital pharmacies currently dominate the market for food allergy, contrary to the general distribution of medicines. First, anaphylaxis patients may need immediate access to epinephrine autoinjectors which can be provided by hospitals in severe cases. Second, specialists in hospital settings often administer and monitor OIT, a promising treatment, which requires on-site access to medicinal products.

Food Allergy Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global market shareholder and is expected to expand substantially during the forecast period. The scene of food allergy in North America is growing exponentially. The market is driven by an alarming rise in allergies, especially for children. As a result, there is a demand for better diagnostics, lifesaving epinephrine for emergencies, and a wider variety of allergen-free foods. From diagnosis to delicious, safe meals, the market caters to managing food allergies across the board.

  • The United States food allergy market. The United States is likely the dominant player within North America's food allergy market due to its large population, high prevalence of allergies, and advanced medical facilities.
  • The Canadian food allergy industry. Canada's market is growing due to growing awareness of food allergies, coupled with an increase in diagnoses, which fuels demand for solutions.

These factors are estimated to drive the North American food allergy industry growth.

North America Food Allergy Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Food Allergy Market Trends

The Asia Pacific region is a pivotal market for the food allergy industry. The market in Asia Pacific will also be stimulated by the increasing focus of key players on expanding into new Asian markets, a large customer base and rising awareness about food allergies.

  • China food allergy industry. China is a major player due to its large population and rising disposable income, leading to increased healthcare spending and demand for allergy solutions.
  • Japan food allergy market. Japan already has a high level of awareness of food allergy and a developed healthcare infrastructure, which is expected to contribute to the growth of the market.

Thus, the factors above are estimated to boost the Asia-Pacific food allergy market growth.

List of Key and Emerging Players in Food Allergy Market

Nutra Respiro
Marksans Pharma Ltd.
AdvaCare Pharma
Bayer AG
ALK
Novartis Pharmaceuticals Corporation
Prota Therapeutics
Aimmune Therapeutics
Aravex
ALS Limited

Key Industry Developments

June 2026
Nestlé Health Science expanded its food allergy nutrition portfolio through continued development of specialized nutritional solutions for individuals with food allergies and intolerances. The company focused on advancing medical nutrition products designed to support allergy management and improve dietary options for affected populations.
May 2026
DBV Technologies advanced its Viaskin™ peanut allergy immunotherapy program through continued clinical and regulatory activities. The company focused on improving non-invasive epicutaneous immunotherapy approaches using its proprietary skin patch technology to support peanut allergy treatment.
April 2026
ALK-Abelló expanded its allergy immunotherapy research and development activities with continued investments in diagnostic and treatment solutions for allergic diseases, including food-related allergies. The company focused on advancing precision allergy care through improved testing methods and immunotherapy technologies.
February 2026
Aimmune Therapeutics expanded its peanut allergy treatment initiatives following continued commercialization and development activities around PALFORZIA®, the first FDA-approved oral immunotherapy product for peanut allergy. The company focused on improving treatment accessibility and supporting healthcare providers in allergy management.

Report Scope

Segmentation

By Treatment 4
  • Antihistamines
  • Adrenaline
  • Oral Immunotherapy
  • Others
By Distribution Channel 3
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Nutra Respiro · Marksans Pharma Ltd. · AdvaCare Pharma · Bayer AG · ALK
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The food allergy market size is valued at USD 42.27 Billion in 2026 and is projected to reach USD 63.89 Billion by 2034, at a CAGR of 5.3% during the forecast period 2026-2034.
North America dominated the market with a share of 38.4% in 2025.
The leading players in this market are Nutra Respiro, Marksans Pharma Ltd., AdvaCare Pharma, Bayer AG, ALK.
The food allergy market is projected to grow at a CAGR of 5.3% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now